News
-
NeoPhore raises £15.2m to advance vital cancer pathway
Cambridge cancer therapy specialist NeoPhore has raised a £15.2 million Series B round to advance its DNA mismatch repair pipeline. The syndicate... Read More
-
Cambridge helps drive optics technology for Ellume Covid test
Australian digital diagnostics company Ellume has revealed the revolutionary technology created in partnership with innovation hothouse Cambridge... Read More
-
Child’s play as Christie sells two Suffolk nurseries
Specialist business property adviser Christie & Co has announced the sale of Bridge Farm and Rendlesham Nurseries in Woodbridge, Suffolk.... Read More
-
42 Technology up to scratch for Swiss partner
Cambridgeshire business 42 Technology and Swiss company INFICON AG – one of the world’s leading industrial sensor enterprises – have collaborated on... Read More
-
HSBC launches £325m SME fund for Cambs and Suffolk
HSBC has launched a £325 million fund for small and medium-sized enterprises in Cambridgeshire & Suffolk – part of a broader £15 billion lending... Read More
-
Crane firm aims for fresh heights after MBO
Falcon Tower Cranes, the UK’s largest independent tower crane supplier, has completed a management buyout which installs a new generation of... Read More
-
Firm cashing in on soaring video games demand
East of England technology enabler Universally Speaking has received a major investment from private equity investor Phoenix Equity Partners to... Read More
-
Record revenues but ambitious Midwich keeps the cheque book open
Audio Visual distributor Midwich Group plc is eyeing further acquisitions and global expansion after posting record revenues for the year to December... Read More
-
US potential dwarfs EU for record-busting Science Group plc
Cambridge tech consultancy Science Group plc saw its share price leap 24.30p (7.71 per cent) to 339.30p after posting record revenues and adjusting... Read More
-
Marshall Motors continues to defy gravity with market-mauling results
Reported pre-tax profit higher, sales all round well ahead of the markets and a show of appreciation from shareholders. Not a bad reaction for... Read More
-
FDA grants key designation for Inivata’s RaDaR™ assay
Cambridge-based liquid biopsy leader Inivata is poised to transform the delivery of technology to help detect residual disease – where some cancer... Read More
-
Cambridge role in groundbreaking superbug research
Groundbreaking genetic research from Cambridge and Norwegian scientists has mapped the evolution of a prolific strain of bacteria and sparked calls... Read More
-
Cambridge dials into world-first sustainable office retrofit
The University of Cambridge Institute for Sustainability Leadership (CISL) has announced the start of works on its new visionary headquarters.... Read More
-
Cambridge appeal crucial as coronavirus heightens blindness crisis in Zimbabwe
Cambridge charity CBM is warning that hundreds of thousands of people are living needlessly blind in Zimbabwe – and the situation is worsening due to... Read More
-
Citrix hiring engineers in Cambridge after $2.25bn acquisition
Citrix Systems, based locally at Cambridge Science Park, is hiring for a variety of engineers for its local operations as it continues to grow... Read More
-
Triple alliance to ‘Quell’ autoimmune diseases
A tripartite UK-Portugal alliance is set to advance the search for drugs to fight autoimmune diseases and neuroinflammation. IONTAS in Cambridge... Read More
-
Cyted named in NHS Innovation Accelerator
Cambridge startup Cyted reveals that its platform has been chosen as one of 12 UK innovators to scale across England’s NHS with support from the NHS... Read More
-
Abcam shares nosedive as H1 profit is almost halved
Cambridge company Abcam, which supplies life science tools to global customers, saw its UK share price fall 147p to 1,385p on Monday morning after a... Read More
-
Buy-out heralds fresh future for workspace design expert COEL
The future looks bright for employees at COEL – the leading office design and fit-out specialists – following a management buy-out. The... Read More
-
Avacta shares leap as test detects new Covid variants
Avacta’s UK share price rose 10.50p (5.28 per cent) as its rapid antigen test was confirmed to detect SARS-CoV-2 new variants. The Cambridge... Read More